Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silence Therapeutics (SLN) Intangibles: 2019-2024

Historic Intangibles for Silence Therapeutics (SLN) over the last 6 years, with Dec 2024 value amounting to $312,000.

  • Silence Therapeutics' Intangibles fell 10.51% to $300,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $300,000, marking a year-over-year decrease of 10.51%. This contributed to the annual value of $312,000 for FY2024, which is 13.81% down from last year.
  • Latest data reveals that Silence Therapeutics reported Intangibles of $312,000 as of FY2024, which was down 13.81% from $362,000 recorded in FY2023.
  • In the past 5 years, Silence Therapeutics' Intangibles registered a high of $396,035 during FY2022, and its lowest value of $137,404 during FY2020.
  • Its 3-year average for Intangibles is $356,678, with a median of $362,000 in 2023.
  • Its Intangibles has fluctuated over the past 5 years, first soared by 121.42% in 2022, then decreased by 13.81% in 2024.
  • Over the past 5 years, Silence Therapeutics' Intangibles (Yearly) stood at $137,404 in 2020, then skyrocketed by 30.17% to $178,864 in 2021, then surged by 121.42% to $396,035 in 2022, then declined by 8.59% to $362,000 in 2023, then dropped by 13.81% to $312,000 in 2024.